QQ客服 官方微博 反馈留言

	Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors
	Wang, Yuhong[1]; Wang, Wei[2]; Jin, Kaizhou[3]; Fang, Cheng[2]; Lin, Yuan[4]; Xue, Ling[4]; Feng, Shiting[5]; Zhou, Zhiwei[2]; Shao, Chenghao[6]; Chen, Minhu[1]
刊名	ONCOLOGY LETTERS
	2017
卷号	13页码:1165-1174
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2186256
专题	华南理工大学
作者单位	1.[1]Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 1, 58 Zhongshan 2 Rd, Guangzhou 510080, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510080, Guangdong, Peoples R China 3.[3]Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Oncol, 270 An Dong Rd, Shanghai 200032, Peoples R China 4.[4]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China 5.[5]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China 6.[6]Second Mil Med Univ, Changzheng Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China
推荐引用方式 GB/T 7714	Wang, Yuhong[1],Wang, Wei[2],Jin, Kaizhou[3],et al. Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors[J]. ONCOLOGY LETTERS,2017,13:1165-1174.
APA	Wang, Yuhong[1].,Wang, Wei[2].,Jin, Kaizhou[3].,Fang, Cheng[2].,Lin, Yuan[4].,...&Chen, Jie[1].(2017).Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.ONCOLOGY LETTERS,13,1165-1174.
MLA	Wang, Yuhong[1],et al."Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors".ONCOLOGY LETTERS 13(2017):1165-1174.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。